E. Kamphuis, “Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry”, Acta Derm Venereol, vol. 104, p. adv19454, Feb. 2024.